Literature DB >> 25687269

Prostate cancer: Hypofractionation not associated with reduced toxicity.

Rebecca Kelsey.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25687269     DOI： 10.1038/nrurol.2015.27

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.

Authors:  Shafak Aluwini; Floris Pos; Erik Schimmel; Emile van Lin; Stijn Krol; Peter Paul van der Toorn; Hanja de Jager; Maarten Dirkx; Wendimagegn Ghidey Alemayehu; Ben Heijmen; Luca Incrocci
Journal:  Lancet Oncol       Date:  2015-02-03       Impact factor: 41.316
  1 in total
  1 in total

1.  Dose-volume analysis of predictors for acute anal toxicity after radiotherapy in prostate cancer patients.

Authors:  Xingsi Peng; Sha Zhou; Shiliang Liu; Jibin Li; Sijuan Huang; Xiaobo Jiang; Maosheng Lin; Shaomin Huang; Chengguang Lin; Chaonan Qian; Mengzhong Liu; Liru He
Journal:  Radiat Oncol       Date:  2019-10-10       Impact factor: 3.481
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.